Table 3 Demographic-subgroup analysis for each discharge category and the study population
Whole population | Home with no rehab needs | Home with community support | Short-stay rehabilitation facility (<6 weeks) | Long-stay rehabilitation facility (>6 weeks) | Nursing home level of care | Nonsurvival from ICU | Nonsurvival from hospital | |
|---|---|---|---|---|---|---|---|---|
N [%] | 499 | 171 [34.3%] | 131 [26.3%] | 28 [5.6%] | 25 [5.0%] | 27 [5.4%] | 80 [16.0%] | 37 [7.4%] |
Age (mean (SD)) | 62.3 [18.31] | 56.2 [17.41] | 63.4 [18.33] | 72.5 [12.1] | 56.0 [15.8] | 56.6 [24.56] | 68.4 [16.37] | 72 [14.04] |
APACHE II (median (IQR)) | 16 [10–20] | 14 [11-18] | 16 [13–21] | 17 [13–20] | 17 [11–20] | 17 [16–24] | 22 [18–24] | 18 [16–22] |
Mean ICU length of stay (SD) | 11.54 [16.18] | 6.44 [5.48] | 11.27 [12.86] | 21.7 [26.6] | 33.28 [41.6] | 15.0 [17.5] | 13.0 [12.3] | 8.74 [7.8] |
Median ICU length of stay (days (IQR)) | 6 [4-12] | 4.5 [3-8] | 6.8 [3-14] | 9 [4–31] | 14.2 [9–43] | 7.1 [5–19] | 9.3 [4-15] | 5.9 [4-11] |
Diagnosis (n (1%)) | ||||||||
- Cardiac arrest | 19 [3.8%] | 1 [0.6%] | 5 [3.8%] | 0 | 0 | 2 [7.4%] | 10 [12.5%] | 1 [2.7%] |
- Chronic cardiovascular disease | 21 [4.2%] | 2 [1.2%] | 11 [8.4%] | 3 [10.7%] | 1 [4%] | 2 [7.4%] | 0 | 2 [7.4%] |
- Cardiovascular dysfunction | 19 [3.8%] | 7 [4.1%] | 4 [3.1%] | 3 [10.7%] | 0 | 1 [3.7%] | 4 [5%] | 0 |
- Cardiovascular monitoring | 9 [1.8%] | 4 [2.3%] | 2 [1.5%] | 0 | 0 | 0 | 1 [1,3%] | 2 [7.4%] |
- Diabetic ketoacidosis | 3 [0.6%] | 3 [1.8%] | 0 [0%] | 0 | 0 | 0 | 0 | 0 |
- Gastrointestinal dysfunction | 67 [13.4%] | 25 [14.6%] | 20 [12.3%] | 4 [14.3%] | 1 [4%] | 3 [11.1%] | 8 [10%] | 6 [22.2%] |
- Gastrointestinal surgery | 38 [7.6%] | 18 [10.5%] | 12 [9.2%] | 2 [7.1%] | 0 | 2 [7.4%] | 4 [5%] | 0 |
- Metabolic/Renal system dysfunction | 39 [7.8%] | 11 [6.4%] | 11 [8.4%] | 6 [21.4%] | 3 [12%] | 0 | 6 [7.5%] | 2 [7.4%] |
- Neurological system dysfunction | 30 [6.0%] | 5 [2.3%] | 8 [6.1%] | 1 [3.6%] | 4 [16%] | 3 [11.1%] | 6 [7.5%] | 3 [11.1%] |
- Poisoning | 4 [0.8%] | 4 [2.3%] | 0 | 0 | 0 | 0 | 0 | 0 |
- Hemorrhage | 11 [2.2%] | 7 [4.1%] | 0 | 0 | 0 | 0 | 1[1.3%] | 3 [11.1%] |
- Respiratory system dysfunction | 148 [29.7%] | 54 [32%] | 37 [28.3%] | 6 [21.4%] | 5 [20%] | 9 [33.3%] | 24 [30%] | 13 [48.1%] |
- Sepsis | 70 [14.0%] | 25 [14.6%] | 16 [12.2%] | 2 [7.1%] | 7 [28%] | 1 [3.7%] | 14 [17.5%] | 5 [18.5%] |
- Trauma | 10 [2.0%] | 0 | 3 [2.3%] | 1 [3.6%] | 2 [8%] | 4 [14.8%] | 0 [0%] | 0 |
- Other | 11 [2.2%] | 5 [2.9%] | 2 [1.5%] | 0 | 2 [8%] | 0 | 2 [2.5%] | 0 |